Effects of photodynamic therapy on tumor stroma

Qian Peng1, Jahn M Nesland

  • 1Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway. qian.peng@labmed.uio.no

Insights

Photodynamic therapy (PDT) effectively targets tumor stroma, including vasculature and cellular components. This approach, combined with parenchyma destruction, is crucial for effective cancer treatment and warrants further investigation for immune-based therapies.

Area of Science:

  • Oncology
  • Biochemistry
  • Photomedicine

Background:

  • Photodynamic therapy (PDT) utilizes photosensitizers and light for targeted tissue destruction.
  • Approved since 1993, PDT treats various oncological and non-oncological conditions.
  • Research interest remains high, with over 500 annual publications.

Purpose of the Study:

  • To review the effects of PDT on tumor stroma.
  • To highlight the importance of targeting both tumor parenchyma and stroma.
  • To explore the potential of PDT-induced immune responses.

Main Methods:

  • Literature review of preclinical and clinical studies on PDT and tumor stroma.
  • Analysis of PDT mechanisms targeting stromal components.
  • Examination of PDT's role in vascular damage and immune modulation.

Main Results:

  • PDT effectively targets tumor stroma, including vasculature, cellular components, and the intercellular matrix.
  • Effective tumor destruction requires targeting both neoplastic cells (parenchyma) and stroma.
  • Damage to the subendothelial zone of vasculature is a critical factor in PDT efficacy.

Conclusions:

  • PDT offers a versatile approach to targeting tumor stroma.
  • Combined targeting of parenchyma and stroma is essential for successful PDT outcomes.
  • Harnessing PDT-induced immune responses presents a promising avenue for cancer treatment and prevention.

Related Concept Videos